An observational, cohort study of ceftaroline in patients with spinal infections caused by gram-positive pathogens

Trial Profile

An observational, cohort study of ceftaroline in patients with spinal infections caused by gram-positive pathogens

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Dec 2016

At a glance

  • Drugs Ceftaroline fosamil (Primary)
  • Indications Gram-positive infections; Methicillin-resistant Staphylococcus aureus infections
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms DISC
  • Most Recent Events

    • 27 Dec 2016 New trial record
    • 30 Oct 2016 Results of preliminary analysis (n=24) presented at the IDWeek 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top